These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 3345727

  • 21. C-cell hyperplasia accompanying thyroid diseases other than medullary carcinoma: an immunocytochemical study by means of antibodies to calcitonin and somatostatin.
    Scopsi L, Di Palma S, Ferrari C, Holst JJ, Rehfeld JF, Rilke F.
    Mod Pathol; 1991 May; 4(3):297-304. PubMed ID: 1676840
    [Abstract] [Full Text] [Related]

  • 22. Expression of gastrin-releasing peptide (human bombesin) gene in large cell undifferentiated carcinoma of the lung.
    Hamid QA, Corrin B, Dewar A, Hoefler H, Sheppard MN.
    J Pathol; 1990 Jun; 161(2):145-51. PubMed ID: 2166149
    [Abstract] [Full Text] [Related]

  • 23. Identification of binding sites for C-terminal pro-gastrin-releasing peptide (GRP)-derived peptides in renal cell carcinoma: a potential target for future therapy.
    Ischia J, Patel O, Sethi K, Nordlund MS, Bolton D, Shulkes A, Baldwin GS.
    BJU Int; 2015 May; 115(5):829-38. PubMed ID: 25130393
    [Abstract] [Full Text] [Related]

  • 24. Nonconstitutive expression of the gastrin-releasing peptide autocrine growth system in human small cell lung carcinoma NCI-H345 cells.
    Aguayo SM, Miller Y, Boose D, Holley M, Portanova LB, Schuyler KD, Kane MA.
    Cell Growth Differ; 1996 May; 7(5):563-72. PubMed ID: 8732666
    [Abstract] [Full Text] [Related]

  • 25. Elevation of serum pro-gastrin-releasing peptide in patients with medullary thyroid carcinoma and small cell lung carcinoma.
    Ide A, Ashizawa K, Ishikawa N, Ishii R, Ando T, Abe Y, Sera N, Usa T, Tominaga T, Ejima E, Nakashima M, Ito K, Ito K, Eguchi K.
    Thyroid; 2001 Nov; 11(11):1055-61. PubMed ID: 11762716
    [Abstract] [Full Text] [Related]

  • 26. Evidence for the presence of gastrin-releasing peptide immunoreactivity in rat anterior pituitary corticotrophs and lactotrophs, AtT20 cells, and GH3 cells: failure to demonstrate participation in local control of hormone release.
    Houben H, Denef C.
    Endocrinology; 1991 Jun; 128(6):3208-18. PubMed ID: 1645264
    [Abstract] [Full Text] [Related]

  • 27. Evidence for autocrine actions of neuromedin B and gastrin-releasing peptide in non-small cell lung cancer.
    Siegfried JM, Krishnamachary N, Gaither Davis A, Gubish C, Hunt JD, Shriver SP.
    Pulm Pharmacol Ther; 1999 Jun; 12(5):291-302. PubMed ID: 10545285
    [Abstract] [Full Text] [Related]

  • 28. Heterogeneous distribution of thyrotrophin receptor messenger ribonucleic acid (TSH-R mRNA) in papillary thyroid carcinomas detected by in situ hybridization.
    Tanaka K, Inoue H, Miki H, Komaki K, Monden Y.
    Clin Endocrinol (Oxf); 1996 Mar; 44(3):259-67. PubMed ID: 8729520
    [Abstract] [Full Text] [Related]

  • 29. Gastrin-releasing peptide immunoreactivity in medullary thyroid carcinoma.
    Matsubayashi S, Yanaihara C, Ohkubo M, Fukata S, Hayashi Y, Tamai H, Nakagawa T, Miyauchi A, Kuma K, Abe K.
    Cancer; 1984 Jun 01; 53(11):2472-7. PubMed ID: 6370416
    [Abstract] [Full Text] [Related]

  • 30. Over-expression of gastrin-releasing peptide in human esophageal squamous cell carcinomas.
    Fang MZ, Liu C, Song Y, Yang GY, Nie Y, Liao J, Zhao X, Shimada Y, Wang LD, Yang CS.
    Carcinogenesis; 2004 Jun 01; 25(6):865-71. PubMed ID: 14764456
    [Abstract] [Full Text] [Related]

  • 31. Observations favouring the occurrence of local production and marked effects of bombesin/gastrin-releasing peptide in the synovial tissue of the human knee joint--comparisons with substance P and the NK-1 receptor.
    Grimsholm O, Rantapää-Dahlqvist S, Dalén T, Forsgren S.
    Neuropeptides; 2008 Apr 01; 42(2):133-45. PubMed ID: 18289674
    [Abstract] [Full Text] [Related]

  • 32. HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias.
    Chiappetta G, Ferraro A, Vuttariello E, Monaco M, Galdiero F, De Simone V, Califano D, Pallante P, Botti G, Pezzullo L, Pierantoni GM, Santoro M, Fusco A.
    Eur J Cancer; 2008 May 01; 44(7):1015-21. PubMed ID: 18375116
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.
    Rhoden KJ, Unger K, Salvatore G, Yilmaz Y, Vovk V, Chiappetta G, Qumsiyeh MB, Rothstein JL, Fusco A, Santoro M, Zitzelsberger H, Tallini G.
    J Clin Endocrinol Metab; 2006 Jun 01; 91(6):2414-23. PubMed ID: 16595592
    [Abstract] [Full Text] [Related]

  • 35. Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation.
    Markwalder R, Reubi JC.
    Cancer Res; 1999 Mar 01; 59(5):1152-9. PubMed ID: 10070977
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Ghrelin in fetal thyroid and follicular tumors and cell lines: expression and effects on tumor growth.
    Volante M, Allia E, Fulcheri E, Cassoni P, Ghigo E, Muccioli G, Papotti M.
    Am J Pathol; 2003 Feb 01; 162(2):645-54. PubMed ID: 12547722
    [Abstract] [Full Text] [Related]

  • 39. Simultaneous detection of messenger ribonucleic acids for bombesin/gastrin-releasing peptide and its receptor in rat brain by nonradiolabeled double in situ hybridization.
    Wang D, Cutz E.
    Lab Invest; 1994 May 01; 70(5):775-80. PubMed ID: 8196371
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.